Huntingdale, Australia

Katherinie Macfarlane

This inventor holds 1 USPTO granted patent. Top assignee: Avexa Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katherinie Macfarlane. Retrieved from https://idiyas.com/inventor/katherinie-macfarlane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katherinie Macfarlane: Innovator in Pharmaceutical Chemistry

Introduction

Katherinie Macfarlane is a notable inventor based in Huntingdale, Australia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can be used in the treatment of viral infections.

Latest Patents

Katherinie holds a patent for "Bicyclic pyrimidinones and uses thereof." This invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt, or prodrug thereof. The patent outlines a method for the treatment or prophylaxis of a viral infection in a subject by administering an effective amount of the compound. Additionally, it includes a pharmaceutical composition or medicament comprising the compound.

Career Highlights

Katherinie is associated with Avexa Limited, a company focused on developing innovative therapies. His work has led to advancements in the pharmaceutical industry, particularly in antiviral treatments.

Collaborations

Katherinie has collaborated with notable colleagues, including Eric Dale Jones and Jonathan Alan Victor Coates. These partnerships have contributed to the success of his research and development efforts.

Conclusion

Katherinie Macfarlane's work in pharmaceutical chemistry exemplifies innovation in the treatment of viral infections. His contributions through patents and collaborations highlight the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…